Biomarin Pharmaceutical Stock Pattern Recognition Rickshaw Man

BMRN Stock  USD 64.26  0.81  1.28%   
Biomarin Pharmaceutical pattern recognition tool provides the execution environment for running the Rickshaw Man recognition and other technical functions against Biomarin Pharmaceutical. Biomarin Pharmaceutical value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of pattern recognition indicators. As with most other technical indicators, the Rickshaw Man recognition function is designed to identify and follow existing trends. Biomarin Pharmaceutical momentum indicators are usually used to generate trading rules based on assumptions that Biomarin Pharmaceutical trends in prices tend to continue for long periods.

Recognition
The output start index for this execution was ten with a total number of output elements of fifty-one. The function generated a total of four valid pattern recognition events for the selected time horizon. The Rickshaw Man may indicate Biomarin Pharmaceutical indecision reversal trend.

Biomarin Pharmaceutical Technical Analysis Modules

Most technical analysis of Biomarin Pharmaceutical help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Biomarin from various momentum indicators to cycle indicators. When you analyze Biomarin charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Biomarin Pharmaceutical Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Biomarin Pharmaceutical. We use our internally-developed statistical techniques to arrive at the intrinsic value of Biomarin Pharmaceutical based on widely used predictive technical indicators. In general, we focus on analyzing Biomarin Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Biomarin Pharmaceutical's daily price indicators and compare them against related drivers, such as pattern recognition and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Biomarin Pharmaceutical's intrinsic value. In addition to deriving basic predictive indicators for Biomarin Pharmaceutical, we also check how macroeconomic factors affect Biomarin Pharmaceutical price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2021 2022 2023 2024 (projected)
Days Sales Outstanding73.8280.3395.6196.45
PTB Ratio3.784.173.663.99
Hype
Prediction
LowEstimatedHigh
60.8963.4566.01
Details
Intrinsic
Valuation
LowRealHigh
56.3358.8969.80
Details
Naive
Forecast
LowNextHigh
62.4965.0567.60
Details
26 Analysts
Consensus
LowTargetHigh
106.42116.95129.81
Details

Become your own money manager

As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.

Did you try this?

Run Options Analysis Now

   

Options Analysis

Analyze and evaluate options and option chains as a potential hedge for your portfolios
All  Next Launch Module

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Gambling Idea
Gambling
Invested over 90 shares
Macroaxis Index Idea
Macroaxis Index
Invested few shares
Warren Buffett Holdings Idea
Warren Buffett Holdings
Invested over 60 shares
Business Services Idea
Business Services
Invested over 100 shares
Banking Idea
Banking
Invested over 20 shares
Baby Boomer Prospects Idea
Baby Boomer Prospects
Invested over 40 shares
Investor Favorites Idea
Investor Favorites
Invested few shares
Blockchain Idea
Blockchain
Invested few shares
Momentum Idea
Momentum
Invested over 50 shares
Chemicals Idea
Chemicals
Invested over 30 shares
Manufacturing Idea
Manufacturing
Invested over 30 shares
ESG Investing Idea
ESG Investing
Invested few shares
When determining whether Biomarin Pharmaceutical offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biomarin Pharmaceutical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biomarin Pharmaceutical Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biomarin Pharmaceutical Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biomarin Pharmaceutical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
To learn how to invest in Biomarin Stock, please use our How to Invest in Biomarin Pharmaceutical guide.
You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biomarin Pharmaceutical. If investors know Biomarin will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biomarin Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
1.607
Earnings Share
1.66
Revenue Per Share
14.529
Quarterly Revenue Growth
0.283
Return On Assets
0.03
The market value of Biomarin Pharmaceutical is measured differently than its book value, which is the value of Biomarin that is recorded on the company's balance sheet. Investors also form their own opinion of Biomarin Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Biomarin Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biomarin Pharmaceutical's market value can be influenced by many factors that don't directly affect Biomarin Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biomarin Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biomarin Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biomarin Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.